白介素8抗体

白介素8（IL-8/CXCL8）抗体是一种针对趋化因子IL-8的一抗，主要用于科研领域的免疫组化（IHC）、免疫印迹（Western Blot）等实验。IL-8是一种中性粒细胞、嗜碱性粒细胞和T细胞的趋化因子，参与炎症反应和细胞活化。不同剪切体（如IL-8（6-77）、IL-8（5-77））在受体结合（CXCR1/CXCR2）和生物活性上存在差异。‌

商品详情
英文别名：Interleukin-8; Interleukin 8; Interleukin8; (Ala-IL-8)77; (Ser-IL-8)72; 3 10C; 310C; AMCF 1; AMCF1; b ENAP; Bbeta thromboglobulin like protein; beta thromboglobulin like protein; C-X-C motif chemokine 8; CXC chemokine ligand 8; CXCL 8; CXCL8; Emoctakin; GCP 1; GCP-1; GCP/IL-8 protein I; GCP/IL-8 protein II; GCP/IL-8 protein III; GCP/IL-8 protein IV; GCP/IL-8 protein V; GCP/IL-8 protein VI; GCP1; Granulocyte chemotactic protein 1; IL 8; IL-8; IL-8(1-77); IL-8(9-77); IL8; IL8/NAP1 form I; IL8/NAP1 form II; IL8/NAP1 form III; IL8/NAP1 form IV; IL8/NAP1 form V; IL8/NAP1 form VI; IL8_HUMAN; Inteleukin 8; Interleukin8; K 60; K60; LECT; LUCT; Lymphocyte derived neutrophil activating factor; Lymphocyte-derived neutrophil-activating factor; LYNAP; MDNCF; MDNCF-b; MDNCF-c; MONAP; Monocyte derived neutrophil activating peptide; Monocyte derived neutrophil activating protein; Monocyte derived neutrophil chemotactic factor; Monocyte-derived neutrophil chemotactic factor; Monocyte-derived neutrophil-activating peptide; NAF; NAP 1; NAP-1; NAP1; Neutrophil activating factor; Neutrophil activating peptide 1; Neutrophil activating protein 1; Neutrophil-activating factor; Neutrophil-activating protein 1; Protein 3 10C; Protein 3-10C; SCYB 8; SCYB8; Small inducible cytokine subfamily B member 8; T cell chemotactic factor; T-cell chemotactic factor; TSG 1; TSG1.
产品应用：WB=1:500-2000, IHC-P=1:100-500, IHC-F=1:100-500
交叉反应：Human
抗体来源：Rabbit
免疫原：Recombinant human IL-8/CXCL8 protein
亚型;IgG

性状:Liquid
纯化方法:affinity purified by Protein A
克隆类型:Polyclonal
克隆号:None

浓度:1mg/ml

储存液：0.01M TBS(pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.<br>
保存条件:Shipped at 4℃. Store at -20 °C for one year. Avoid repeated freeze/thaw cycles.
注意事项:This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.

应用范围

研究领域：趋化因子信号通路、炎症反应、细胞表面分子互作。

实验方法：适用于免疫组化、Western Blot等，需根据具体实验优化稀释比例。

使用注意事项

样本处理：

血清/血浆样本需避免反复冻融，建议分装保存于-20℃。

细胞培养上清需离心去除颗粒物。

抗体保存：

液态抗体短期保存于4℃，长期需-20℃冻存；冻干粉常温运输，溶解后分装冻存。

实验优化：

建议预实验确定最佳稀释比例（参考范围：WB 1:500-1:2000，IHC 1:50-1:200）。

质量控制 

抗体经KLH偶联合成肽段（CST）或天然蛋白免疫制备，通过ELISA或免疫亲和层析验证特异性。

提供批间差报告。
公司正在出售的产品

图